ArriVent BioPharma Partners with Alphamab to Develop Cutting-Edge Cancer Treatments
SUZHOU, China and NEWTOWN SQUARE, PA — ArriVent BioPharma, Inc. announced a strategic collaboration with Jiangsu Alphamab Biopharmaceuticals Co., Ltd. (“Alphamab”) to develop and commercialize novel antibody drug conjugates (ADCs) …
ArriVent BioPharma Partners with Alphamab to Develop Cutting-Edge Cancer Treatments Read More